Quarterly ResultMay 12, 2026, 07:07 AM
Neuraxis Q1 Net Sales +79.5% to $1.61M; Loss Per Share $(0.18)
AI Summary
Neuraxis reported a significant increase in net sales for Q1 2026, rising 79.5% to $1.61 million, with gross profit up 83.7% to $1.39 million. The company reduced its net loss to $(1.76) million from $(2.28) million in the prior year, and loss per share improved to $(0.18). Cash and stockholders' equity saw substantial growth due to financing activities, though the company continues to operate at a loss and has a going concern warning.
Key Highlights
- Net sales increased 79.5% to $1,607,883 for Q1 2026 from $895,655 in Q1 2025.
- Gross profit rose 83.7% to $1,389,517 in Q1 2026 from $756,180 in Q1 2025.
- Net loss improved to $(1,761,432) in Q1 2026 from $(2,278,684) in Q1 2025.
- Basic and diluted loss per share improved to $(0.18) in Q1 2026 from $(0.33) in Q1 2025.
- Cash and cash equivalents increased to $7,078,659 as of March 31, 2026, from $4,965,072.
- Total stockholders' equity grew to $5,747,550 as of March 31, 2026, from $3,399,372.
- Net cash used in operating activities decreased to $(1,229,757) from $(1,603,655).
- Company issued a going concern warning due to continued losses and reliance on financing.
Price Impact
More from NRXS